Comparison of an intraoperative infusion of dexmedetomidine or remifentanil on perioperative haemodynamics, hypnosis and sedation, and postoperative pain control

Journal of International Medical Research

Volumn 39, Issue 5, 2011, Pages 1890-1899

  Jung, H S ^a   Joo, J D ^a   Jeon, Y S ^a   Lee, J A ^a   Kim, D W ^a   In, J H ^a   Rhee, H Y ^a   Choi, J W ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Anaesthetic Agents; Dexmedetomidine; Laparoscopic Hysterectomy; Postanaesthetic Care Unit; Postoperative Haemodynamic Stability; Remifentanil

Indexed keywords

DEXMEDETOMIDINE; REMIFENTANIL;

ADULT; AGED; ALERTNESS; ARTICLE; BLOOD PRESSURE MONITORING; BRADYCARDIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; HYPNOSIS; HYPOTENSION; HYSTERECTOMY; INTRAOPERATIVE PERIOD; LAPAROSCOPIC SURGERY; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SCORING SYSTEM; SEDATION; SHIVERING; VOMITING; XEROSTOMIA;

EID: 80155161941     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900533     Document Type: Article

References (36)

1. Ebert TJ, Hall JE, Barney JA, et al: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-394.
2. Hall JE, Uhrich TD, Barney JA, et al: Sedative, amnestic, and analgesic properties of smalldose dexmedetomidine infusions. Anesth Analg 2000; 90: 699-705.
3. Venn RM, Hell J, Grounds RM: Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Critical Care 2000; 4: 302-308.
4. Herr DL, Sum-Ping ST, England M: ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003; 17: 576-584.
5. Kamibayashi T, Maxe M: Clinical uses of 52-adrenergic agonists. Anesthesiology 2000; 93: 1345-1350.
6. Panzer O, Moitra V, Sladen RN: Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin 2009; 25: 451-469.
7. Bloor BC, Ward DS, Belleville JP, et al: Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: 1134-1142.
8. Bekker A, Sturaitis MK: Dexmedetomidine for neurological surgery. Neurosurgery 2005; 57(1 suppl): 1-10.
9. Yaksh TL, Pogrel JW, Lee YW, et al: Reversal of nerve ligation-induced allodynia by spinal n-2 adrenoreceptor agonists. J Pharmacol Exp Ther 1995; 272: 207-214.
10. Bürkle H, Dunbar S, Van Aken H: Remifentanil: a novel, short-acting, μ-opioid. Anesth Analg 1996; 83: 646-651.
11. Egan TD, Lemmens HJ, Fiset P, et al: The pharmacokinetics of the new short-acting opioid remifentanil (G187084B) in healthy adult male volunteers. Anesthesiology 1993; 79: 881-892.
12. Hawkins JL: American Society of Anesthesiologists' Practice Guidelines for Obstetric Anesthesia: update 2006. Int J Obstet Anesth 2007; 16: 103-105.
13. Chernik DA, Gillings D, Laine H, et al: Validity and reliability of the observer's assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 1990; 10: 244-251.
14. Shin HW, Ban YJ, Lee HW, et al: Arousal with iv epinephrine depends on the depth of anesthesia. Can J Anaesth 2004; 51: 880-885.
15. Busick T, Kussman M, Scheidt T, et al: Preliminary experience with dexmedetomidine for monitored anesthesia care during ENT surgical procedures. Am J Ther 2008; 15: 520-527.
16. Bauerle K, Greim CA, Schroth M, et al: Prediction of depth of sedation and anaesthesia by the Narcotrend™ EEG monitor. Br J Anaesth 2004; 92: 841-845.
17. Jaakola ML: Dexmedetomidine premedication before intravenous regional anesthesia in minor outpatient hand surgery. J Clin Anesth 1994; 6: 204-211.
18. Dyck JB, Maze M, Haack C, et al: The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 813-820.
19. Mester R, Easley RB, Brady KM, et al: Monitored anesthesia care with a combination of ketamine and dexmedetomidine during cardiac catheterization. Am J Ther 2008; 15: 24-30.
20. Choi JW, Joo JD, In JH, et al: The comparison of sedation quality, side effect and recovery profiles of propofol alone, propofol-fentanyl and propofol-ketamine PCS for MAC. Korean J Anesthesiol 2006; 50: 428-433 [in Korean].
21. Shukry M, Miller JA: Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical procedures. Ther Clin Risk Manag 2010; 6: 111-121.
22. Joo HS, Kapoor S, Rose DK, et al: The intubating laryngeal mask airway after induction of general anesthesia versus awake fiberoptic intubation in patients with difficult airways. Anesth Analg 2001; 92: 1342-1346.
23. Maze M, Segal IS, Bloor BC: Clonidine and other alpha2 adrenergic agonists: strategies for the rational use of these novel anesthetic agents. J Clin Anesth 1988; 1: 146-157.
24. Guo TZ, Jiang JY, Buttermann AE, et al: Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology 1996; 84: 873-881.
25. Arain SR, Ruehlow RM, Uhrich TD, et al: The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 2004; 98: 153-158.
26. Cohen LB, Delegge MH, Aisenberg J, et al: AGA Institute review of endoscopic sedation. Gastroenterology 2007; 133: 675-701.
27. Choi JW, Kim DW, In JH, et al: Comparison of an intraoperative infusion of dexmedetomidine or fentanyl for the perioperative hemodynamics, achieving hypnosis and sedation, and the postoperative pain control. Anesth Pain Med 2011; 6: 125-130 [in Korean].
28. Wilhelm W, Dorscheid E, Schlaich N, et al: The use of remifentanil in critically ill patients. Clinical findings and early experience. Anaesthesist 1990; 48: 625-629 [in German, English abstract].
29. Tipps LB, Coplin WM, Murry KR, et al: Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care unit. Neurosurgery 2000; 46: 596-602.
30. Cavaliere F, Antonelli M, Arcangeli A, et al: A low-dose remifentanil infusion is well tolerated for sedation in mechanically ventilated, critically-ill patients. Can J Anaesth 2002; 49: 1088-1094.
31. Rampil IJ: A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89: 980-1002.
32. Sigl JC, Chamoun NG: An introduction to bispectral analysis for the electro-encephalogram. J Clin Monit 1994; 10: 392-404.
33. Lu J, Nelson LE, Franks N, et al: Role of endogenous sleep-wake and analgesic systems in anesthesia. J Comp Neurol 2008; 508: 648-662.
34. Hall JE, Uhrich TD, Barney JA, et al: Sedative, amnestic, and analgesic properties of smalldose dexmedetomidine infusions. Anesth Analg 2000; 90: 699-705.
35. Granholm M, McKusick BC, Westerholm FC, et al: Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole. Vet Anaesth Analg 2006; 33: 214-223.
36. El Bahri L: Atipamezole. Compend Contin Educ Vet 2008; 30: 256-258.